At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
OsseoSpeed™ TX 3.0Sdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Prospective, Single Arm, Multi-centre Study Evaluating OsseoSpeed™ Implant 3 mm Diameter Replacing a Central or Lateral Mandibular Incisor or Lateral Maxillary Incisor. A 5-year Follow-up Study.
In Brief
A clinical study evaluating OsseoSpeed™ TX 3.0S for Jaw, Edentulous, Partially. Completed, enrolled 72 participants across 6 sites in 6 countries.
Detailed Summary
To evaluate 5-year survival, functionality and safety for OsseoSpeed™ 3.0 mm diameter implant when used for single tooth crown in positions 12, 22, 31, 32, 41 and 42. The primary hypothesis is that implant survival after 5 years is equal to what has been observed with comparable implants in current literature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJaw, Edentulous, Partially
CountriesDenmark, Germany, Italy, Spain, Sweden, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMar 2008
Primary CompletionAug 2014
TodayJul 2026
First PostedMar 28, 2008
Enrollment StartMar 1, 2008
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 18.3 years ago
Interventions
OsseoSpeed™ TX 3.0Sdevice
OsseoSpeed™ TX 3.0 mm diameter